Endra Life Sciences Inc (NDRA)

$4.39 -0.15 (-3.30%)
Market Cap 3.42M
Revenue (ttm) 0.00
Net Income (ttm) -11.51M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 28,200
Avg Vol 2,024,048
Day's Range N/A - N/A
Shares Out 753,000.00
Stochastic %K 42%
Beta -0.18
Analysts Sell
Price Target $46.00

Company Profile

ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is involved in the development of thermo-acoustic enhanced ultrasound technology that uses pulsed energy source comprising radio frequency to transmit energy deep into tissue and generate ultrasonic waves to create high-contrast images for use in the treatment of non-alcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 734 335 0468
Address:
3600 Green Court, Suite 350, Ann Arbor, United States
JFZ
JFZ Aug. 21 at 11:07 AM
$EVOK $NDRA $OPEN $RILY $WULF
0 · Reply
Winning_calls
Winning_calls Aug. 18 at 4:26 AM
$NDRA pick me up @ $4.95
0 · Reply
PhishTourFunds
PhishTourFunds Aug. 18 at 2:02 AM
$NDRA 💥
0 · Reply
YouVSYou
YouVSYou Aug. 18 at 12:39 AM
Golden cross setups to watch this week: $OPEN $WULF $NDRA $RILY $EVOK
1 · Reply
TATTED_KEN
TATTED_KEN Aug. 15 at 6:10 PM
$NDRA waiting to close the gap. Patiently adding $LICN 🎯 $7
0 · Reply
Hassan_Ben_Sober
Hassan_Ben_Sober Aug. 15 at 2:41 PM
$NDRA Why can't you buy this in fidelity?
0 · Reply
dndodd
dndodd Aug. 15 at 12:03 AM
$NDRA the only thing this has going for it is the low float plenty of dilution in bound. Just look at the stock performance over the last 5 years -$31,397.56 and that is not a misprint.
1 · Reply
WatchAndTrip
WatchAndTrip Aug. 13 at 8:04 PM
$MLSS $NDRA $WBUY $ JG watchlists
0 · Reply
TATTED_KEN
TATTED_KEN Aug. 13 at 7:15 PM
$NDRA $DFSC I’m expecting this 2 to run AH 🤞🏼
0 · Reply
TATTED_KEN
TATTED_KEN Aug. 13 at 6:33 PM
$UPC ripping. Adding $NDRA
0 · Reply
Latest News on NDRA
ENDRA Life Sciences Provides a Business Update and Reports Second Quarter 2025 Financial Results

Aug 14, 2025, 4:05 PM EDT - 8 days ago

ENDRA Life Sciences Provides a Business Update and Reports Second Quarter 2025 Financial Results

ENDRA's Ongoing Multisite Pilot Study Reveals Important Enhancements to Boost TAEUS Liver Accuracy and Repeatability Against MRI Gold Standard

Jun 16, 2025, 8:00 AM EDT - 2 months ago

ENDRA's Ongoing Multisite Pilot Study Reveals Important Enhancements to Boost TAEUS Liver Accuracy and Repeatability Against MRI Gold Standard

ENDRA Life Sciences Provides a Business Update and Reports First Quarter 2025 Financial Results

May 15, 2025, 4:05 PM EDT - 3 months ago

ENDRA Life Sciences Provides a Business Update and Reports First Quarter 2025 Financial Results

ENDRA Life Sciences Announces Enhanced Strategy to Enable the Early Detection and Management of Metabolic Diseases Facilitated by Emerging GLP-1 Therapies

Mar 31, 2025, 8:05 AM EDT - 5 months ago

ENDRA Life Sciences Announces Enhanced Strategy to Enable the Early Detection and Management of Metabolic Diseases Facilitated by Emerging GLP-1 Therapies

ENDRA Life Sciences Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides a Business Update

Mar 31, 2025, 8:00 AM EDT - 5 months ago

ENDRA Life Sciences Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides a Business Update

ENDRA Life Sciences Regains Compliance with Nasdaq Minimum Bid Price Requirement

Nov 22, 2024, 8:00 AM EST - 9 months ago

ENDRA Life Sciences Regains Compliance with Nasdaq Minimum Bid Price Requirement

ENDRA Life Sciences Reports Third Quarter 2024 Financial Results and Provides a Business Update

Nov 15, 2024, 9:24 AM EST - 10 months ago

ENDRA Life Sciences Reports Third Quarter 2024 Financial Results and Provides a Business Update

Study Highlighting ENDRA Life Sciences' TAEUS Technology in Patients with High BMI to be Presented at AASLD's The Liver Meeting® 2024

Nov 12, 2024, 8:00 AM EST - 10 months ago

Study Highlighting ENDRA Life Sciences' TAEUS Technology in Patients with High BMI to be Presented at AASLD's The Liver Meeting® 2024

ENDRA Life Sciences Further Strengthens TAEUS® Platform Intellectual Property with Issuance of 17th European Patent

Nov 6, 2024, 8:00 AM EST - 10 months ago

ENDRA Life Sciences Further Strengthens TAEUS® Platform Intellectual Property with Issuance of 17th European Patent

ENDRA Life Sciences Activates TAEUS System to Initiate Clinical Study at LMU University Hospital in Germany

Oct 22, 2024, 8:00 AM EDT - 10 months ago

ENDRA Life Sciences Activates TAEUS System to Initiate Clinical Study at LMU University Hospital in Germany

Data I/O And 2 Other Stocks Under $5 Executives Are Buying

Aug 30, 2024, 8:54 AM EDT - 1 year ago

Data I/O And 2 Other Stocks Under $5 Executives Are Buying

DAIO

ENDRA Life Sciences Granted Extension to Regain Compliance with Nasdaq Continued Listing Requirements

Aug 28, 2024, 4:17 PM EDT - 1 year ago

ENDRA Life Sciences Granted Extension to Regain Compliance with Nasdaq Continued Listing Requirements

ENDRA Life Sciences Inc. (NDRA) Q2 2024 Earnings Call Transcript

Aug 22, 2024, 5:54 PM EDT - 1 year ago

ENDRA Life Sciences Inc. (NDRA) Q2 2024 Earnings Call Transcript

ENDRA Life Sciences Reports Second Quarter 2024 Financial Results and Provides a Business Update

Aug 22, 2024, 4:14 PM EDT - 1 year ago

ENDRA Life Sciences Reports Second Quarter 2024 Financial Results and Provides a Business Update

ENDRA Life Sciences Announces Reverse Stock Split

Aug 16, 2024, 8:00 AM EDT - 1 year ago

ENDRA Life Sciences Announces Reverse Stock Split

ENDRA Life Sciences Reschedules Second Quarter Conference Call to August 22, 2024

Aug 13, 2024, 4:05 PM EDT - 1 year ago

ENDRA Life Sciences Reschedules Second Quarter Conference Call to August 22, 2024

ENDRA Life Sciences Announces Leadership Changes

Aug 13, 2024, 8:00 AM EDT - 1 year ago

ENDRA Life Sciences Announces Leadership Changes

ENDRA Life Sciences to Report Second Quarter 2024 Financial Results on August 14

Aug 7, 2024, 8:00 AM EDT - 1 year ago

ENDRA Life Sciences to Report Second Quarter 2024 Financial Results on August 14

ENDRA Life Sciences Announces Pricing of $8.0 Million Public Offering

Jun 4, 2024, 9:21 AM EDT - 1 year ago

ENDRA Life Sciences Announces Pricing of $8.0 Million Public Offering

AM Best to Host Webinar on Engaging Defense Counsel Pre-Lawsuit

Jun 4, 2024, 9:06 AM EDT - 1 year ago

AM Best to Host Webinar on Engaging Defense Counsel Pre-Lawsuit

ENDRA Provides Update Following In-person Meeting with FDA

May 20, 2024, 8:00 AM EDT - 1 year ago

ENDRA Provides Update Following In-person Meeting with FDA

ENDRA Life Sciences Inc. (NDRA) Q1 2024 Earnings Call Transcript

May 14, 2024, 8:30 PM EDT - 1 year ago

ENDRA Life Sciences Inc. (NDRA) Q1 2024 Earnings Call Transcript

ENDRA Life Sciences Reports First Quarter 2024 Financial Results and Provides a Business Update

May 14, 2024, 4:05 PM EDT - 1 year ago

ENDRA Life Sciences Reports First Quarter 2024 Financial Results and Provides a Business Update

ENDRA Life Sciences to Report First Quarter 2024 Financial Results on May 14, 2024

May 7, 2024, 8:00 AM EDT - 1 year ago

ENDRA Life Sciences to Report First Quarter 2024 Financial Results on May 14, 2024

ENDRA Life Sciences Strengthens Intellectual Property with Issuance of Five New International Patents

May 2, 2024, 8:00 AM EDT - 1 year ago

ENDRA Life Sciences Strengthens Intellectual Property with Issuance of Five New International Patents

ENDRA Life Sciences Inc. (NDRA) Q4 2023 Earnings Call Transcript

Mar 28, 2024, 9:10 PM EDT - 1 year ago

ENDRA Life Sciences Inc. (NDRA) Q4 2023 Earnings Call Transcript

ENDRA Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Mar 28, 2024, 4:05 PM EDT - 1 year ago

ENDRA Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

ENDRA Life Sciences to Report Fourth Quarter 2023 Financial Results on March 28, 2024

Mar 21, 2024, 8:00 AM EDT - 1 year ago

ENDRA Life Sciences to Report Fourth Quarter 2023 Financial Results on March 28, 2024

ENDRA Life Sciences Installs First TAEUS System in the UK

Feb 27, 2024, 8:00 AM EST - 1 year ago

ENDRA Life Sciences Installs First TAEUS System in the UK

New ICD-10-CM Code by the World Health Organization Paves the Way for Improved NAFLD Diagnostics Including ENDRA Life Sciences' TAEUS System

Feb 21, 2024, 8:00 AM EST - 1 year ago

New ICD-10-CM Code by the World Health Organization Paves the Way for Improved NAFLD Diagnostics Including ENDRA Life Sciences' TAEUS System

ENDRA Life Sciences Bolsters TAEUS® System Intellectual Property with New Patents in U.S., China and Europe

Feb 14, 2024, 8:30 AM EST - 1 year ago

ENDRA Life Sciences Bolsters TAEUS® System Intellectual Property with New Patents in U.S., China and Europe

ENDRA Life Sciences Secures 39th U.S. Patent for TAEUS® System Technology

Nov 29, 2023, 8:00 AM EST - 1 year ago

ENDRA Life Sciences Secures 39th U.S. Patent for TAEUS® System Technology

ENDRA Life Sciences to Participate in The Benchmark Company's 12th Annual Discovery One-on-One Investor Conference

Nov 27, 2023, 8:00 AM EST - 1 year ago

ENDRA Life Sciences to Participate in The Benchmark Company's 12th Annual Discovery One-on-One Investor Conference

ENDRA Life Sciences Inc. (NDRA) Q3 2023 Earnings Call Transcript

Nov 14, 2023, 10:14 PM EST - 1 year ago

ENDRA Life Sciences Inc. (NDRA) Q3 2023 Earnings Call Transcript

ENDRA Life Sciences Reports Third Quarter 2023 Financial Results and Provides Business Update

Nov 14, 2023, 4:05 PM EST - 1 year ago

ENDRA Life Sciences Reports Third Quarter 2023 Financial Results and Provides Business Update

ENDRA Life Sciences Achieves Intellectual Property Milestone with Issuance of Three New Patents

Nov 8, 2023, 8:00 AM EST - 1 year ago

ENDRA Life Sciences Achieves Intellectual Property Milestone with Issuance of Three New Patents

ENDRA Life Sciences to Report Third Quarter 2023 Financial Results on November 14, 2023

Nov 7, 2023, 4:05 PM EST - 1 year ago

ENDRA Life Sciences to Report Third Quarter 2023 Financial Results on November 14, 2023

ENDRA to Host Multidisciplinary Clinical Discussion on Managing Liver Disease During AASLD's The Liver Meeting® 2023

Nov 6, 2023, 8:00 AM EST - 1 year ago

ENDRA to Host Multidisciplinary Clinical Discussion on Managing Liver Disease During AASLD's The Liver Meeting® 2023

Abstract for ENDRA Life Sciences' TAEUS System Accepted for Presentation at EASL Steatotic Liver Disease Summit 2023

Sep 7, 2023, 8:00 AM EDT - 2 years ago

Abstract for ENDRA Life Sciences' TAEUS System Accepted for Presentation at EASL Steatotic Liver Disease Summit 2023

ENDRA Life Sciences' TAEUS De Novo Submission Advances to Next Stage of Review with FDA

Aug 30, 2023, 8:00 AM EDT - 2 years ago

ENDRA Life Sciences' TAEUS De Novo Submission Advances to Next Stage of Review with FDA

ENDRA Life Sciences Expands Intellectual Property with Issuance of U.S. and European Patents

Aug 23, 2023, 8:00 AM EDT - 2 years ago

ENDRA Life Sciences Expands Intellectual Property with Issuance of U.S. and European Patents

ENDRA Life Sciences Inc. (NDRA) Q2 2023 Earnings Call Transcript

Aug 14, 2023, 9:44 PM EDT - 2 years ago

ENDRA Life Sciences Inc. (NDRA) Q2 2023 Earnings Call Transcript

ENDRA Life Sciences Reports Second Quarter 2023 Financial Results and Provides a Business Update

Aug 14, 2023, 4:05 PM EDT - 2 years ago

ENDRA Life Sciences Reports Second Quarter 2023 Financial Results and Provides a Business Update

ENDRA Life Sciences Submits De Novo Request for its TAEUS® System Liver Fat Application to the U.S. FDA

Aug 14, 2023, 1:30 PM EDT - 2 years ago

ENDRA Life Sciences Submits De Novo Request for its TAEUS® System Liver Fat Application to the U.S. FDA

ENDRA Life Sciences to Report Second Quarter 2023 Financial Results on August 14, 2023

Aug 1, 2023, 8:00 AM EDT - 2 years ago

ENDRA Life Sciences to Report Second Quarter 2023 Financial Results on August 14, 2023

ENDRA Life Sciences Announces Adjournment of 2023 Annual Meeting of Stockholders to July 25, 2023

Jul 6, 2023, 4:45 PM EDT - 2 years ago

ENDRA Life Sciences Announces Adjournment of 2023 Annual Meeting of Stockholders to July 25, 2023

Study Highlighting ENDRA Life Sciences' TAEUS Technology to be Presented at EASL International Liver Congress 2023

Jun 7, 2023, 8:00 AM EDT - 2 years ago

Study Highlighting ENDRA Life Sciences' TAEUS Technology to be Presented at EASL International Liver Congress 2023

ENDRA Life Sciences Inc. (NDRA) Q1 2023 Earnings Call Transcript

May 15, 2023, 9:48 PM EDT - 2 years ago

ENDRA Life Sciences Inc. (NDRA) Q1 2023 Earnings Call Transcript

ENDRA Life Sciences Reports First Quarter 2023 Financial Results and Provides a Business Update

May 15, 2023, 4:05 PM EDT - 2 years ago

ENDRA Life Sciences Reports First Quarter 2023 Financial Results and Provides a Business Update

ENDRA Life Sciences to Report First Quarter 2023 Financial Results on May 15, 2023

May 4, 2023, 8:00 AM EDT - 2 years ago

ENDRA Life Sciences to Report First Quarter 2023 Financial Results on May 15, 2023

JFZ
JFZ Aug. 21 at 11:07 AM
$EVOK $NDRA $OPEN $RILY $WULF
0 · Reply
Winning_calls
Winning_calls Aug. 18 at 4:26 AM
$NDRA pick me up @ $4.95
0 · Reply
PhishTourFunds
PhishTourFunds Aug. 18 at 2:02 AM
$NDRA 💥
0 · Reply
YouVSYou
YouVSYou Aug. 18 at 12:39 AM
Golden cross setups to watch this week: $OPEN $WULF $NDRA $RILY $EVOK
1 · Reply
TATTED_KEN
TATTED_KEN Aug. 15 at 6:10 PM
$NDRA waiting to close the gap. Patiently adding $LICN 🎯 $7
0 · Reply
Hassan_Ben_Sober
Hassan_Ben_Sober Aug. 15 at 2:41 PM
$NDRA Why can't you buy this in fidelity?
0 · Reply
dndodd
dndodd Aug. 15 at 12:03 AM
$NDRA the only thing this has going for it is the low float plenty of dilution in bound. Just look at the stock performance over the last 5 years -$31,397.56 and that is not a misprint.
1 · Reply
WatchAndTrip
WatchAndTrip Aug. 13 at 8:04 PM
$MLSS $NDRA $WBUY $ JG watchlists
0 · Reply
TATTED_KEN
TATTED_KEN Aug. 13 at 7:15 PM
$NDRA $DFSC I’m expecting this 2 to run AH 🤞🏼
0 · Reply
TATTED_KEN
TATTED_KEN Aug. 13 at 6:33 PM
$UPC ripping. Adding $NDRA
0 · Reply
DetectingRunners
DetectingRunners Aug. 12 at 7:40 PM
$NDRA nice daily reversal potential
0 · Reply
DayTrade_4Life
DayTrade_4Life Aug. 12 at 12:31 AM
Stocks with Recent Surge in Short Interest. $MRNY, $SONN, $NDRA, $SXTP, $SGN
1 · Reply
PaulLaurent
PaulLaurent Aug. 11 at 7:29 PM
📈⚠️ Stocks with Recent Surge in Short Interest ⚠️📈 $MRNY $LRHC $SONN $SXTP $NDRA
1 · Reply
AnudderBrainlessMoron
AnudderBrainlessMoron Aug. 11 at 3:35 AM
$NDRA Trump wins again!
0 · Reply
Lizardbronsen
Lizardbronsen Aug. 8 at 6:59 PM
$MRM $MKZR $NDRA
0 · Reply
Baba200TradeBot
Baba200TradeBot Aug. 8 at 12:30 PM
LowFloatReport.com - ⬆️ - Top 5 Low Float Gap Up Stay Up (Premarket 2) as of 08/08/25 - 8:30 AM $CLIK - Volume: 25.9M - Prev Volume: 333K - Float: 5.09 - Rel Vol: 49.6x - Chng%: +6.5% $MKZR - Volume: 202K - Prev Volume: 101K - Float: 1.62 - Rel Vol: 137.8x - Chng%: +22.0% $REAL - Volume: 1.2M - Prev Volume: 3.6M - Float: 90.5 - Rel Vol: 7.5x - Chng%: +26.1% $OUST - Volume: 107K - Prev Volume: 1.4M - Float: 48.22 - Rel Vol: 0.7x - Chng%: +20.4% $NDRA - Volume: 423K - Prev Volume: 15K - Float: 0.75 - Rel Vol: 5.2x - Chng%: +0.2%
0 · Reply
Baba200TradeBot
Baba200TradeBot Aug. 8 at 11:30 AM
LowFloatReport.com - ⬆️ - Top 5 Low Float Gap Up Stay Up (Premarket 1) as of 08/08/25 - 7:30 AM $CLIK - Volume: 20.0M - Prev Volume: 333K - Float: 5.09 - Rel Vol: 38.3x - Chng%: +11.4% $MKZR - Volume: 140K - Prev Volume: 101K - Float: 1.62 - Rel Vol: 95.3x - Chng%: +20.4% $REAL - Volume: 778K - Prev Volume: 3.6M - Float: 90.5 - Rel Vol: 4.7x - Chng%: +29.2% $NDRA - Volume: 367K - Prev Volume: 15K - Float: 0.75 - Rel Vol: 4.5x - Chng%: +3.8% $ORIS - Volume: 217.7M - Prev Volume: 29.1M - Float: 3.21 - Rel Vol: 542.6x - Chng%: +107.0%
0 · Reply
WatchAndTrip
WatchAndTrip Aug. 8 at 10:34 AM
$NDRA
0 · Reply
BigSqueezeComing
BigSqueezeComing Aug. 8 at 9:27 AM
$NDRA gapping up today!!!
0 · Reply
frankyboyz
frankyboyz Aug. 8 at 7:03 AM
Support and retweet: #frankysWL 🔥 The one and only Franky’s Watchlist 🔥 Aug. 8, 2025 "Sharm El-Sheikh" Edition 🌴 Your daily dose of high-potential setups & sharp trade ideas to stay ahead. 🤑 💥 Afterhours Movers – Let’s Dive In: 💥 ━━━━━━━━━━━━━━━━━━━━━ $MRM $MKZR $NDRA https://x.com/frankyboyz_ofcl/status/1953713543896805677 Franky
0 · Reply
PaulLaurent
PaulLaurent Aug. 8 at 5:24 AM
🚀📈 Top Gainers 📈🚀 $MKZR $CLIK $NDRA $OPRX $ABCL
0 · Reply
Pipelinepivots
Pipelinepivots Aug. 8 at 5:11 AM
Watch ticker - IBG its now 40% shorted! I have been early on many big plays, this one SCREAMS parabolic / life changing potential. $MRM $MKZR $CLIK $NDRA
0 · Reply